CGA has been shown to reduce oxidative damage, control the inflammatory response through inhibition of TNF-α, IL-6, and IL-1β, increase insulin sensitivity, and prevent CVD and obesity through lipid metabolism modulation [16]. Here, IL1B is linked to obesity due to melanocortin 4 receptor deficiency.